Publications by authors named "W Phongsamart"
Article Synopsis
- Adoption of HPV vaccination in the Asia-Pacific region is low compared to Europe and America, with limited comprehensive reviews on HPV's impact in these areas.
- A systematic literature review analyzed 254 publications from 2000 to 2022, revealing significant incidence and prevalence rates for cervical, head and neck, anal, penile, and vaginal/vulvar cancers, but found a lack of detailed studies on costs or healthcare resource utilization.
- The findings indicate a high burden of HPV-related diseases, highlighting the urgent need for better HPV screening, increased education, reduced vaccine hesitancy, and improved data collection to inform health policies.
There is limited literature on current human papillomavirus (HPV) vaccination in the Asia-Pacific region. This integrative literature review was conducted to describe HPV vaccination programs in Hong Kong, Indonesia, Japan, South Korea, Malaysia, the Philippines, Singapore, Taiwan, Thailand, and Vietnam. Program descriptions, recommendations, f unding, and coverage data were extracted.
View Article and Find Full Text PDFCorrigendum to "Adipocytokine dysregulation, abnormal glucose metabolism, and lipodystrophy in HIV-infected adolescents receiving protease inhibitors" [Cytokine 136 (2020) 155145].
Cytokine
August 2024
Introduction: There are gaps in knowledge and experience of antiretroviral pre-exposure prophylaxis (PrEP) delivery in adolescents.
Methods: This pilot study enrolled Thai adolescents 14-20 year-old without HIV who reported risk behaviour. All participants were offered daily tenofovir/emtricitabine (TDF-FTC) and followed for 24 weeks.
Objective: To compare the immune response of hybrid immunity - arising from SARS-CoV-2 infection and mRNA BNT162b2 vaccination - to that of 2-doses of vaccine.
Methods: In a subanalysis of BNT162b2 vaccine trial in 5 to 11-year-old children, There were 179 children who had hybrid immunity compared with 134 children with solely 2-dose vaccine. The immunological outcome was a surrogate virus neutralization test (sVNT) against the Omicron strain, BA.